title: Effect of oral glutamine supplementation during bone marrow transplantation.
abstract: BACKGROUND
  Because all patients receiving bone marrow transplant (BMT) and peripheral blood progenitor cell transplant (PBPCT) experience gastrointestinal (GI) toxicity from the preparative regimen of chemotherapy, with or without radiation, oral glutamine was administered during the preparatory regimen and after transplant to maintain GI structure and function.
  
  
  METHODS
  To evaluate effects of oral glutamine on nutritional status and overall outcome, a prospective, randomized, double-blinded study was performed on 58 autologous and allogeneic BMT patients. Patients received 30 g of oral glutamine or placebo daily.
  
  
  RESULTS
  The trends of decreased median length of stay and the median number of days of total parenteral nutrition (TPN) were seen in the group supplemented with the >0.285-g/kg (the recommended dosage) dose of glutamine; however, there was no statistically significant difference in the nutritional status and overall patient outcome as assessed by days receiving TPN, number of days required until oral intake resumed, length of hospitalization, number of days and highest grade of mucositis, and quantity and number of days of diarrhea.
  
  
  CONCLUSIONS
  This study does not support the hypothesis that oral glutamine may offer benefit. Further investigation is required regarding clinical tools for determining effectiveness, administration for tolerance and compliance, dosage, and potential of oral glutamine usage.
authors.affiliation: Department of Clinical Nutrition, Stanford University Medical Center, California 94305, USA. coghlin_i@hose.stanford.edu
authors.forename: T M
authors.initials: TM
authors.lastname: Coghlin Dickson
authors.forename: R M
authors.initials: RM
authors.lastname: Wong
authors.forename: R S
authors.initials: RS
authors.lastname: offrin
authors.forename: J A
authors.initials: JA
authors.lastname: Shizuru
authors.forename: L J
authors.initials: LJ
authors.lastname: Johnston
authors.forename: W W
authors.initials: WW
authors.lastname: Hu
authors.forename: K G
authors.initials: KG
authors.lastname: Blume
authors.forename: K E
authors.initials: KE
authors.lastname: Stockerl-Goldstein
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D004311:Double-Blind Method; D005260:Female; D005973:Glutamine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007902:Length of Stay; D007938:Leukemia / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009752:Nutritional Status; D010289:Parenteral Nutrition, Total
chemical_list: D005973:Glutamine